0
SPEAKER_01
Coming up next on PassionStruck.
0
SPEAKER_00
Immunotherapy, the KRAS targeted therapy, and then things that disrupt that dense stromal that is characteristic of pancreatic cancer.
0
SPEAKER_00
Things that will loosen that up and let drugs in better and let things work better.
0
SPEAKER_00
I was a third area
0
SPEAKER_00
of research.
0
SPEAKER_00
And I think if we can learn how to use those three approaches, those things that make pancreatic cancer so difficult to treat, then we can get to the point where we can really start to control it and see lots of cases of long-term survivors.
0
SPEAKER_00
Welcome to Passion Struck.
0
SPEAKER_01
Hi, I m your host, John R. Miles, and on the show, we decipher the secrets, tips, and guidance of the world s most inspiring people and turn their wisdom into practical advice for you and those around you.
0
SPEAKER_01
Our mission is to help you unlock the power of intentionality so that you can become the best version of yourself.
0
SPEAKER_01
If you re new to the show, I offer advice and answer listener questions on Fridays.
0
SPEAKER_01
We have long-form interviews the rest of the week with guests ranging from astronauts to authors, CEOs, creators, innovators, scientists, military leaders, visionaries, and athletes.
0
SPEAKER_01
Now, let s go out there and become passionstruck.
0
SPEAKER_01
Hello everyone, I am so glad to welcome you back to episode 373 of Passion Struck, which is consistently ranked by Apple as the number one alternative health podcast.
0
SPEAKER_01
And thank you to all of you who come back every week to listen and learn how to live better, be better, and impact the world.
0
SPEAKER_01
to the show, thank you so much for being here.
0
SPEAKER_01
Or you simply want to introduce this to a friend or a family member, and we absolutely love it when you do that.
0
SPEAKER_01
We have episode starter packs, which are collections of our fans  favorite episodes that we organize into convenient playlists that give any new listener a great way to get acclimated to everything we do here on the show.
0
SPEAKER_01
Either go to Spotify or passionstruck.com slash starter packs to get started.
0
SPEAKER_01
And in case you missed it, I had an amazing interview earlier in the week with Jim Quick, founder and CEO of Quick Learning, New York Times bestselling author of Limitless and host of the Quick Brain podcast.
0
SPEAKER_01
We discuss how Jim has spent the last 25 years helping people improve their memory, learn to speed read, increase their decision-making skills, and unleash their super brains.
0
SPEAKER_01
An episode that if you haven t listened to it, you definitely want to go and check it out.
0
SPEAKER_01
I also wanted to say thank you for your ratings and reviews, and if you loved today s episode or that one with Jim Quick, we would appreciate you giving it a 5-star review and sharing it with your friends and families.
0
SPEAKER_01
I know we and our guests love to see comments from our listeners.
0
SPEAKER_01
Today s discussion is incredibly close to my heart.
0
SPEAKER_01
As we recognize Pancreatic Cancer Awareness Day, we aim to cast a light on a subject that touches many lives, including my own.
0
SPEAKER_01
My sister Carolyn is currently battling pancreatic cancer, a fight that many of our listeners may know all too well within their own families.
0
SPEAKER_01
In a bid to amplify awareness and foster hope, it is my profound honor to welcome Dr. Lynn Matrician, the Chief Science Officer at the Pancreatic Cancer Action Network, otherwise known as PANCAN.
0
SPEAKER_01
Dr. Matrician s life s work resonates with the urgency and dedication that I have witnessed firsthand in my sister s journey.
0
SPEAKER_01
Her commitment to education and her leadership and research provide invaluable insight into the fight against this formidable disease.
0
SPEAKER_01
Our conversation today is not only timely, but critical.
0
SPEAKER_01
We ll unravel the latest advancements in early detection, a field where PanCan s research is pioneering new paths and offering rays of hope.
0
SPEAKER_01
Education, especially for those in high-risk communities, is paramount, and Lynn s expertise will guide us through understanding which populations are more vulnerable and why.
0
SPEAKER_01
We ll also delve into the specifics of PanCan s mission to educate the public about the risks and symptoms of pancreatic cancer, ensuring that this information reaches the ears that it needs most.
0
SPEAKER_01
Knowledge here is more than power.
0
SPEAKER_01
It s potentially life-saving.
0
SPEAKER_01
Together, we ll explore the new treatment frontiers, discuss how to support those at risk, and learn how every one of us can contribute to the battle against this disease.
0
SPEAKER_01
This episode is dedicated to all the warriors, like my sister Carolyn, who are fighting with grace and courage every day.
0
SPEAKER_01
It s a conversation about hope, about science, and most importantly, about the individuals and families who stand to benefit from these strides in research and awareness.
0
SPEAKER_01
So with a sense of purpose and hope for a future where pancreatic cancer is no longer a silent killer, let s welcome Dr. Lynn Matrusian to this deeply personal and paramount episode of the PassionStruck podcast.
0
SPEAKER_01
Thank you for choosing PassionStruck and choosing me to be your host and guide on your journey to creating an intentional life.
0
SPEAKER_01
Now, let that journey begin.
0
SPEAKER_01
I am so honored today to have Dr. Lynn Matrycion on PassionStruck.
0
SPEAKER_01
Welcome, Lynn.
0
SPEAKER_00
Great to be here.
0
SPEAKER_01
I was hoping we might start out by giving the audience a little bit of information on what personally started your drive and dedication to understanding and fighting cancer.
0
SPEAKER_00
Yes, I think like a lot of people, I was impacted by pancreatic cancer at a relatively early age.
0
SPEAKER_00
I was deciding what I wanted to do with my life.
0
SPEAKER_00
My major was in medical technology, so I was working in a hospital laboratory.
0
SPEAKER_00
They had a research laboratory there and I just fell in love with research.
0
SPEAKER_00
I thought, oh my goodness, you can be the first person to know something, to ask interesting questions.
0
SPEAKER_00
And so I started down that path.
0
SPEAKER_00
And about that time, my elementary school best friend and next door neighbor was diagnosed with cancer.
0
SPEAKER_00
And I had to go say goodbye to her.
0
SPEAKER_00
And on the drive back, I remember saying, if I have any talent in this research stuff, I have to work on cancer.
0
SPEAKER_00
That s what I have to do.
0
SPEAKER_00
And I was lucky enough to get into graduate school and end up doing cancer research.
0
SPEAKER_01
So you went from getting your degree to then really specializing in molecular biology, as I understand it, and cancer metastasis.
0
SPEAKER_01
How close do you think we are to understanding the key drivers of how cancer spreads?
0
SPEAKER_00
What we ve learned about cancer in my lifetime is amazing.
0
SPEAKER_00
I was actually born the year we discovered the DNA was in a helix.
0
SPEAKER_00
And so all these advances that have come from understanding how one cell makes multiple cells and what can go wrong with that to turn a normal cell into a cancer cell, all that s happened in relatively recent years as you think about it.
0
SPEAKER_00
So as we learn more about it, we understand that there are normal processes that get taken over by genetic changes within a cancer cell.
0
SPEAKER_00
And these cells start doing things that they would never ordinarily do.
0
SPEAKER_00
And the real hallmark of cancer is they start spreading to other places.
0
SPEAKER_00
And they think that part of that is that they gain the ability to live in environments they wouldn t ordinarily live in.
0
SPEAKER_00
And this is a survival mechanism.
0
SPEAKER_00
And they seek out environments that will support their growth.
0
SPEAKER_00
And that s why cancer metastasizes.
0
SPEAKER_00
So there s been a lot of really interesting work on really trying to understand that and understanding at the molecular level so that we can figure out how to combat it with drugs and devices like that.
0
SPEAKER_01
On the show, I ve interviewed a bunch of medical professionals about the science of epigenetics and longevity science, people like Mark Hyman, Kara Fitzgerald, and others.
0
SPEAKER_01
And there seems to be a common thread of how lifestyle choices ultimately impact not only your health span, but your lifespan.
0
SPEAKER_01
How much do those lifestyle choices, and we re talking here what you eat, how you sleep, how much exercise you get, your emotional state, how much do those same factors coincide with the outbreak or emergence of cancer?
0
SPEAKER_00
Yeah, it s pretty clear that things like unhealthy metabolism, being overweight, those types of things are risk factors for cancer.
0
SPEAKER_00
And so they do contribute to them.
0
SPEAKER_00
And so healthy lifestyle.
0
SPEAKER_00
good weight management, exercising, fresh air, all those types of things, good diet, all contribute to our overall health and therefore our risk of developing cancer.
0
SPEAKER_00
It s all tied in.
0
SPEAKER_00
We re just amazingly complex machines and ecosystem in how all those things affect our ability to be healthy and our susceptibility to disease.
0
SPEAKER_01
Yeah, and I wanted to touch on one more thing specifically.
0
SPEAKER_01
In this day and age, we seem to be bombarded by information everywhere.
0
SPEAKER_01
Our life seems to be going so much faster than it was even for me a decade ago.
0
SPEAKER_01
And because of that, we have more and more stress that s coming into our lives.
0
SPEAKER_01
Is there any correlation between that chronic stress load and the need to do mindfulness, meditation, exercise, other things, and cancer potentially forming in your body?
0
SPEAKER_00
So those are complex epidemiological studies that need to be done to really answer those questions definitively.
0
SPEAKER_00
But there is data and evidence that those
1
SPEAKER_00
types of things all impact cancer and how we deal with cancer if we get it.
1
SPEAKER_01
If I have it correct, you still are an adjunct professor at Vanderbilt, but you spent about two and a half decades there really doing significant cancer research.
1
SPEAKER_01
What caused you to decide to shift your focus to patient advocacy and to join PanCan?
1
SPEAKER_00
Yeah, I loved my laboratory and my position and it was a really wonderful career.
1
SPEAKER_00
I spent a little bit of time at the National Cancer Institutes and looking at what programs you could put in a national level that would really impact diseases like cancer.
1
SPEAKER_00
And that was really compelling to think about
1
SPEAKER_00
I could do things with my laboratory, I could do things with my department, with my institution, with my colleagues, but here was a way to actually impact it on a national level.
1
SPEAKER_00
I thought there was that there would be some real rewards.
1
SPEAKER_00
in doing that.
1
SPEAKER_00
And I thought that patient advocacy was a way to garner the passion of people that have been impacted by a disease, implement some business principles on top of that, and that together maybe you can
1
SPEAKER_00
could really make some major changes in a field.
1
SPEAKER_00
And I liked the idea of working that closely with individuals impacted with the disease and really passionate about doing something and making it better for the next person who was diagnosed.
1
SPEAKER_00
So I looked into that as a possibility to do for the next stage of my career.
1
SPEAKER_01
Lynn, as you and I were talking before you came on, my sister is a pancreatic cancer survivor.
1
SPEAKER_01
She s currently still battling this deadly disease.
1
SPEAKER_01
But because of that, I have learned far more than I ever anticipated I was going to learn about pancreatic cancer over the past few years.
1
SPEAKER_01
Correct me if what I m saying is incorrect, but my understanding is pancreatic cancer is currently the third leading cause of death from different forms of cancer, and it s on the cusp of becoming the second.
1
SPEAKER_01
primarily because we re finding ways for early detection and to treat other forms of cancer, which is making their prognosis better.
1
SPEAKER_01
And so pancreatic cancer, unfortunately, is moving up the ladder because of that is part one.
1
SPEAKER_01
Is that pretty accurate?
1
SPEAKER_00
Yes.
1
SPEAKER_00
Yep.
1
SPEAKER_00
If you look at those trend lines, and it s a study we did a couple of years ago, that deaths from other cancer types are falling, which is fabulous.
1
SPEAKER_00
And overall it s falling.
1
SPEAKER_00
And so we ve really made real advances.
1
SPEAKER_00
But the line that s going up and not going down is pancreatic cancer.
1
SPEAKER_00
And it will pass colorectal cancer soon and be number two in the number of deaths in this nation.
1
SPEAKER_00
It s not a race that we ever wanted to win and something that really brings home the importance of putting research advances, applying them to this disease.
1
SPEAKER_01
which is why it s so important that we re talking about this on Pancreatic Cancer Awareness Day.
1
SPEAKER_01
My other understanding, and I have a friend from high school, honestly, who s, I can t make this stuff up.
1
SPEAKER_01
She s married to one of the people who s been doing Whipple surgery longer than anyone at Johns Hopkins.
1
SPEAKER_01
My understanding in talking to him and talking to others is pancreatic cancer is so difficult because when you look at the pancreas, protective membrane that is around it, I guess you could say difficult to penetrate that it makes things such as chemotherapy, immunotherapy, other cancer treatment, radiation, much more difficult to interact with the pancreatic cancer cells that are underneath that membrane.
1
SPEAKER_01
Is that a correct understanding?
1
SPEAKER_00
Yep, it s one of those characteristics of pancreatic cancer that looks so different from other cancer types.
1
SPEAKER_00
It builds up scar tissue around the tumor cells that make this very dense, hard,
1
SPEAKER_00
capsule around and throughout the cancer.
1
SPEAKER_00
And that s exactly right.
1
SPEAKER_00
What that does is collapse the blood vessels.
1
SPEAKER_00
Drugs don t get in, can t get to the cancer cells as well.
1
SPEAKER_00
Whether it s because of that or other things, the immune system just doesn t.
1
SPEAKER_00
It s much harder for it to attack pancreatic cancer than other cancer types.
1
SPEAKER_00
It has alterations in a pathway called the KRAS,
1
SPEAKER_00
pathway, and that happens in some other cancers, but it happens in almost all of the pancreatic cancer cases.
1
SPEAKER_00
There s really these things that set pancreatic cancer apart from other cancer types, and we just have to work a little harder to take the things that we learned in other cancer types and make them work in pancreatic cancer.
1
SPEAKER_01
One of the things that I think is so important about what PanCan has been doing is you ve been setting extremely aggressive charts for trying to half the number of pancreatic cancer deaths.
1
SPEAKER_01
And I know you ve set another aggressive target.
1
SPEAKER_01
What are the current survival rates for pancreatic cancers and what factors contribute to improving these rates?
1
SPEAKER_00
Yeah, so we track five-year relative survival rates.
1
SPEAKER_00
So what percent of pancreatic cancer patients diagnosed this year are anticipated to be alive five years from now?
1
SPEAKER_00
And when we started, it was at 4%.
1
SPEAKER_00
when Pan Can started, it s now at 12% and it s gone up 1% each year for the past two years.
1
SPEAKER_00
So I feel like we ve got some momentum going that we re really getting there.
1
SPEAKER_00
And we set aggressive goals.
1
SPEAKER_00
That s we re looking for 20% survival by 2030.
1
SPEAKER_00
And we hold ourselves accountable for that.
1
SPEAKER_00
and the way that you change survival rates is that you try to get better treatments, you try to get earlier diagnosis, you do better supportive care for people who have pancreatic cancer, and the thing that PanCan is so good at is that we look at all those things, that we look at the holistic way
1
SPEAKER_00
of the disease and try to approach it from multiple ways so that we can make that increase in survival that we all so desperately want.
1
SPEAKER_01
I wanted to go more deep into basically early detection, because as I understand it right now, there s different areas that pancreatic cancer can form, like at the head or the tail.
1
SPEAKER_01
One is easier to treat than the other.
1
SPEAKER_01
But Whipple surgery currently seems to be the best option that s available if the disease is caught soon enough.
1
SPEAKER_01
The issue is that it s often detected by the time that it s already metastasized, and therefore it s being caught in stage 3 or stage 4, which limits the treatment options.
1
SPEAKER_01
All that being said, what are some of the ways that you and PanCan are trying to effectively get ahead of this with earlier detection mechanisms?
1
SPEAKER_00
Yes, you re absolutely right.
1
SPEAKER_00
One of the real problems is that so many people are diagnosed and they already have metastatic disease in pancreatic cancer, which isn t necessarily the case at all in many other cancer types, which have much longer survivals.
1
SPEAKER_00
The earlier you catch the disease, the better the survival rate because of things like surgery.
1
SPEAKER_00
Surgery is the best way to get rid of cancer.
1
SPEAKER_00
You simply take it out.
1
SPEAKER_00
And so what we want to do is catch it earlier so that more people will be able to go to surgery and we can improve the overall survival.
1
SPEAKER_00
So how do you do that?
1
SPEAKER_00
So one way is making people aware of symptoms.
1
SPEAKER_00
So that s an important thing about this month of November and today, World Pancreatic Cancer Day, is that s really important that people are aware that what are these symptoms are and to go ask their doctor about it.
1
SPEAKER_00
So they re relatively common symptoms, but if they persist, then you need to go to your doctor and just check it out and see if that s it.
1
SPEAKER_00
but then there are research paths that are being taken for earlier detection.
1
SPEAKER_00
One way is if you have a genetic predisposition, a genetic risk for pancreatic cancer, it s good to know that because you can be screened regularly.
1
SPEAKER_00
and that can catch it very early.
1
SPEAKER_00
That s important.
1
SPEAKER_00
That s about 10% of the cases of pancreatic cancer, so there are research efforts in that area.
1
SPEAKER_00
What we are doing at PanCan is we re very interested in diabetes, new onset diabetes.
1
SPEAKER_00
It looks like type 2 diabetes.
1
SPEAKER_00
It happens to individuals usually over the age of 50, and it s actually a symptom of pancreatic cancer.
2
SPEAKER_00
but it s not recognized as such.
2
SPEAKER_00
And so we think if people would recognize that as a symptom, get an image, a CT scan or an MRI right then and there, that we could catch it much earlier than when it s usually diagnosed, when there s a lot of other symptoms that finally result in a diagnosis.
2
SPEAKER_00
And so we have a research effort to use new onset diabetes as a trigger
2
SPEAKER_00
for the earlier detection of pancreatic cancer.
2
SPEAKER_00
So, those types of things we think that will help.
2
SPEAKER_00
There are blood tests.
2
SPEAKER_00
We would all like to have a blood test for pancreatic cancer.
2
SPEAKER_00
There are blood tests being developed for many cancer types that may work on a general population.
2
SPEAKER_00
They are on the market, but we need more research to really know how good they are for early detection
2
SPEAKER_00
of pancreatic cancer and other cancer types.
2
SPEAKER_00
Those are the types of things that are in the works.
2
SPEAKER_00
It s exciting time research-wise for this.
2
SPEAKER_00
We still have a ways to go, but we re getting there.
2
SPEAKER_01
In terms of genetic testing, does BRCA or having the BRCA gene, which you typically think of having breast cancer or ovarian cancer, is there any link between that and pancreatic cancer?
2
SPEAKER_00
Yes, there is for both BRCA1 and in particular for BRCA2 for the form of the disease.
2
SPEAKER_00
But yes, that s an elevated risk for pancreatic cancer.
2
SPEAKER_00
A lot of people are much more aware of the risk for breast or ovarian cancer and don t realize that pancreatic cancer is also a risk.
2
SPEAKER_00
There are surveillance programs where people with those genetic inherited alterations can get regular screening for pancreatic cancer as well as these other cancer types.
2
SPEAKER_00
And there are several genes as well that predispose to pancreatic cancer and some other types of cancer.
2
SPEAKER_00
We ve learned a lot in the last decade or two about what to look for in terms of risk.
2
SPEAKER_01
A lot of the listeners have heard Maria Menounos  story.
2
SPEAKER_01
I know she s one of your ambassadors right now for this month and for the campaigns that you re running.
2
SPEAKER_01
Her case is a little bit different because I understand that where her cancer is located is not the most aggressive area for pancreatic cancer, but
2
SPEAKER_01
In her case, it was discovered because she was fortunate enough to do a whole body MRI scan.
2
SPEAKER_01
Am I thinking of this correctly?
2
SPEAKER_00
That s my understanding.
2
SPEAKER_01
Okay.
2
SPEAKER_01
Which unfortunately, given its cost is not something that is given out to the general public.
2
SPEAKER_01
Although if it was, it would catch not only a whole bunch of different cancers, but a whole bunch of other things that would probably save the medical insurance company apparatus a lot more money by paying for that test than the repercussions of not doing it.
2
SPEAKER_01
Do you ever foresee this type of testing becoming more common and affordable for the general public?
2
SPEAKER_00
That s a really hard question.
2
SPEAKER_00
In terms of it being recommended as something that everybody should do on a regular basis to catch cancer early, I have a hard time thinking that s ever really going to work.
2
SPEAKER_00
I think that both the cost effectiveness and just the downside, if you weigh the benefits versus the cost and risk and other things that are coming, I don t know for sure.
2
SPEAKER_00
I don t have a crystal ball, but I find it a little hard to think that would be the way that we would go.
2
SPEAKER_00
I think this idea of blood tests that would then narrow down the population and tell you this person is worth looking in this organ to see if they have cancer or not is a much more effective and adaptable approach to cancer screening.
2
SPEAKER_01
Yes.
2
SPEAKER_01
That way you could look at all the masses and start boiling it down to a subset.
2
SPEAKER_01
And then from that subset, you could then take it down to a micro level, which fits more into the common care system that we re all part of today.
2
SPEAKER_01
I m asking all these background questions because in the case of my sister, she did not have breakup.
2
SPEAKER_01
She did not have any of the genes or genetic history to have pancreatic cancer.
2
SPEAKER_01
And when this hit her at 46, you re thinking young and of the spectrum, a person who s working out constantly in very good shape, very mindful about what she s eating, et cetera.
2
SPEAKER_01
And for her, it just started out that she started to feel incredibly tired.
2
SPEAKER_01
doing the daily routines and workouts, et cetera, that she was accustomed to.
2
SPEAKER_01
And she really didn t know what it was until she became jaundiced.
2
SPEAKER_01
And that s what really gave them the inclination that something was amiss.
2
SPEAKER_01
I think that s one of the hard parts about this is when you don t know what s causing that and she wasn t showing signs of being a type two diabetic.
2
SPEAKER_01
It s hard sometimes to figure out what s happening.
2
SPEAKER_00
Yeah.
2
SPEAKER_01
So when you think about all of this, and since you ve been in this role now for quite some time, what are some of the most common misconceptions about pancreatic cancer that you encounter?
2
SPEAKER_00
Well, it is a deadly disease, an aggressive disease, but there is hope and there are things that are being done all the time.
2
SPEAKER_00
So I think the first thing to realize is that there s things to do that if one gets this diagnosis, and unfortunately, like your sister, there isn t always risk factors or any symptoms that give you an indication that something s happened.
2
SPEAKER_00
In the case of jaundice, yes, absolutely.
2
SPEAKER_00
Get that checked out immediately because that is not normal.
2
SPEAKER_00
So that makes sense.
2
SPEAKER_00
What we tell people to do in that case is call PanCan.
2
SPEAKER_00
Call us at the Pancreatic Cancer Action Network.
2
SPEAKER_00
We have trained people on the phones by email that have talked to people before that have been facing this and can really help navigate all the things that need to be done at that particular point in time.
2
SPEAKER_01
Okay.
2
SPEAKER_01
And from your perspective as the chief science officer, what do you think are some of the most promising areas of pancreatic cancer research that are currently underway?
2
SPEAKER_00
There s some exciting new advances in being able to target that KRAS pathway that I was talking about, that so many pancreatic cancer cases are, that s being driven.
2
SPEAKER_00
It s really driving the growth of those cells through this pathway.
2
SPEAKER_00
And we have always considered it undruggable, that it was just not something that we had a drug for.
2
SPEAKER_00
And there s been recent advances over the last, really,
2
SPEAKER_00
couple years that say, oh, that s no longer true.
2
SPEAKER_00
There are drugs that can target this pathway.
2
SPEAKER_00
So that s incredibly exciting, I think, as a real advance.
2
SPEAKER_00
And that should really just shut down the cancer.
2
SPEAKER_00
Now, cancers are really quite resilient.
2
SPEAKER_00
They have a lot of survival mechanisms.
2
SPEAKER_00
And so the approach I like for the people to keep it under control for longer periods of time
2
SPEAKER_00
is to get your own immune system to recognize that as foreign and to keep it under check.
2
SPEAKER_00
And so both immunotherapy, the KRAS targeted therapy, and then things that disrupt that dense stroma we were talking about earlier that is characteristic of pancreatic cancer, things that will loosen that up and let drugs in better and let things work better.
2
SPEAKER_00
I think it was a third area
2
SPEAKER_00
of research.
2
SPEAKER_00
And I think if we can learn how to use those three approaches, those things that make pancreatic cancer so difficult to treat, I think then we can get to the point where we can really start to control it and see lots of cases of long-term survivors.
2
SPEAKER_00
We have long-term survivors.
2
SPEAKER_00
In some cases, we ve figured out how to give those individuals a long and productive and healthy lifespan, but we have to do it for more people.
2
SPEAKER_00
We have to be able to find additional ways to expand that.
2
SPEAKER_01
And I just wanted to make a note here that earlier in the year, I also interviewed Julie Fleshman, who is the CEO of Pan Can, and she and I went really deep into this area.
2
SPEAKER_01
If you re looking for more information, I will put it in the show notes, but that s a great episode to turn back to.
2
SPEAKER_01
Another one that I did about this time last year was my sister and I actually interviewed Dr. Mike Pishvian.
2
SPEAKER_00
Yeah, yeah.
2
SPEAKER_01
who is at Johns Hopkins and is on the forefront of really looking at this next generation of clinical trials that are out there.
2
SPEAKER_01
And some of the advice that he gave, and I wanted to see if this resonates with you, is he said things are changing so quickly that the best thing that a pancreatic
3
SPEAKER_00
cancer patient can do right now is buy themselves time because new treatments are coming out all the time.
3
SPEAKER_00
And he also gave Carolyn advice that the most important thing for her to do is to start really understanding her biomarkers, understanding her gene mutations,
3
SPEAKER_00
because he thinks that is the area where he s seeing the most hope right now.
3
SPEAKER_00
You mentioned it, the KRAS variety, it s typically BCD are the ones, but finding clinical trials or other treatment protocols that go after that.
3
SPEAKER_00
And he said what he s really hopeful for in immunotherapy is that they need to find a delivery vehicle.
3
SPEAKER_00
And he thinks that the way that this is going to happen is through this biomarker and understanding how to use that as a vehicle to penetrate.
3
SPEAKER_00
and then to use immunotherapy to do the treatment.
3
SPEAKER_00
And I know Carolyn has discovered that there are now some clinical trials that are combining the specialized chemotherapy that they re using to go after the biomarkers in combination with immunotherapy that are having some good results.
3
SPEAKER_01
Yep, that sounds just right.
3
SPEAKER_01
And Mike Pishvayan is a wonderful doctor and has done some really amazing work in this area.
3
SPEAKER_01
He s collaborated.
3
SPEAKER_01
He s been quite a good colleague to the Pancreatic Cancer Action Network, and we ve worked together on some studies.
3
SPEAKER_01
We have this Know Your Tumor program where we provide molecular profiling to individuals who call our helpline.
3
SPEAKER_01
And we ve learned from that.
3
SPEAKER_01
And Dr. Pishfayan and I and other colleagues have worked together to understand what that means and how we can then use that for the next patient that we see.
3
SPEAKER_01
And yes, that s exactly right.
3
SPEAKER_01
We can learn so much.
3
SPEAKER_01
I m a molecular biologist.
3
SPEAKER_01
I believe there s information in those molecules
3
SPEAKER_01
that make a cancer different from a normal cell.
3
SPEAKER_01
And if we can understand that, we can then find ways to turn off those pathways, revert that cancer to more of a normal cell.
3
SPEAKER_01
And so these are all ways that people throughout the world, throughout the United States are working on.
3
SPEAKER_01
and you take that basic research, basic understanding it, turn it into clinical trials, something that you can actually treat patients with, and then ask if it really improves outcomes.
3
SPEAKER_01
And that s how we make advances in a disease like this and any disease.
3
SPEAKER_00
Lynn, I m going to switch gears.
3
SPEAKER_00
I know one of the biggest things that PanCan is working on, in addition to early detection and to help people find treatment plans, find clinical trials, is the complex task of education.
3
SPEAKER_00
And I understand that this is especially difficult in high-risk communities.
3
SPEAKER_00
What strategies have proven most effective in trying to reach these high-risk communities?
3
SPEAKER_01
We find that it s really a personal connection that helps people understand the information and makes it important to them, makes it relevant to them.
3
SPEAKER_01
So we have affiliate networks, we have
3
SPEAKER_01
60 plus affiliates across the United States that raise awareness, that raise funds, that educate the community about pancreatic cancer and can say, call PanCan, this is what you need to do.
3
SPEAKER_01
So we find that having people
3
SPEAKER_01
affected by pancreatic cancer who are passionate and understand the importance of people knowing that there s help, knowing, in essence, what steps they need to take.
3
SPEAKER_01
That really is incredibly important.
3
SPEAKER_01
And we do that a lot of times by our personal interactions with people.
3
SPEAKER_01
through our affiliate networks and making this big community across the United States that can help anybody who finds themselves interested and having to know something about pancreatic cancer, whether they wanted to or not.
3
SPEAKER_00
I understand that you guys have a couple of resources that I just wanted to bring to bear in case the audience wanted to access them.
3
SPEAKER_00
One of those, as I understand, you have a 10-question test that helps people to learn more about pancreatic cancer risk factors and what might increase your risk.
3
SPEAKER_00
Where can someone take that test?
3
SPEAKER_01
So go to pancan.org, P-A-N-C-A-N.org.
3
SPEAKER_01
And right now, right on the front page, you ll see information about understanding your risk.
3
SPEAKER_01
There it is again, 10 simple questions.
3
SPEAKER_01
It just gives you a sense of what your risk might be and gives you a place to find out more information and follow that up.
3
SPEAKER_00
Okay, and I also understand you have something called the Family History Worksheet.
3
SPEAKER_00
How would someone use that?
3
SPEAKER_01
Again, go on pancan.org.
3
SPEAKER_01
It s important.
3
SPEAKER_01
The things like how many people in your family have had pancreatic cancer, at what age have they had it, have they had other cancers?
3
SPEAKER_01
These are the types of things that sometimes you have to go digging and you have to ask somebody and ask relatives and fill that out.
3
SPEAKER_01
But it s actually a very good thing to know
3
SPEAKER_01
about what is your family history of cancer in general and will help you understand your risk of pancreatic cancer in particular.
3
SPEAKER_01
So these are all, this worksheet will help you know what questions to ask and to be prepared to take it to your physician and find out, should I get tested for one of these predisposition genes or not?
3
SPEAKER_01
What we really recommend is anybody who s had pancreatic cancer,
3
SPEAKER_01
who has the disease get tested.
3
SPEAKER_01
And that tells us whether we also need to test their relatives or not.
3
SPEAKER_00
I just wanted to bring this up that pancreatic cancer can affect anyone regardless of race.
3
SPEAKER_00
However, it tends to affect Black Americans and Native Americans and some Jewish populations more than others.
3
SPEAKER_00
And I understand that you have a funded study called Regenerate that people in those communities might be interested in as well.
3
SPEAKER_01
Yes, very much.
3
SPEAKER_01
We generate was a very nice study that was done to look at people with pancreatic cancer and identify whether they had a predisposition and then whether their relatives did or not.
3
SPEAKER_01
But it turns out that we had very little diversity in that study.
3
SPEAKER_01
So we learned a lot about white Americans, but we didn t learn a lot about these other populations.
3
SPEAKER_01
We are funding a pilot study to do some very, some focus groups, some good work in
3
SPEAKER_01
understanding how do we reach these communities?
3
SPEAKER_01
How do we ask these people to come and get genetic testing?
3
SPEAKER_01
What do we have to tell them?
3
SPEAKER_01
How do we make it available?
3
SPEAKER_01
How do we make this resource easy to get for them?
3
SPEAKER_01
We re getting ready to publish a paper now on what we ve learned from that study and then apply what we ve learned to expanding that study and actually trying to put it into practice.
3
SPEAKER_00
Okay.
3
SPEAKER_00
Well, and thank you for sharing that.
3
SPEAKER_00
And now I wanted to just go into a little bit about your other mission, which is advocacy and working at both a national level and at a global level.
3
SPEAKER_00
What ways has PanCan s research and advocacy influenced or changed the conversation about pancreatic cancer treatment and patient care?
3
SPEAKER_01
Yeah, certainly we track that whether people know about us, that s been improving in terms of people being aware that we re a resource, we can help them.
3
SPEAKER_01
This is not a community people necessarily want to
3
SPEAKER_01
join, but if you find yourself in that position, we re here to help.
3
SPEAKER_01
This is what we do.
3
SPEAKER_01
This is what we really care about and continue to do that.
3
SPEAKER_01
So our advocacy extends in terms of awareness, but we also do government advocacy.
3
SPEAKER_01
We want to make sure that the National Cancer Institute, that the government has pancreatic cancer on their radar, knows how much it means to us, and that we are affecting that change in that way as well.
3
SPEAKER_00
Okay.
3
SPEAKER_00
And something I just wanted to put out there for the listeners or the viewers is your advocacy matters.
3
SPEAKER_00
The more that you are talking to your senators and Congress and wealthy donors, et cetera, all of this matters because all of this comes down to funding.
3
SPEAKER_00
And a lot of times money is, I understand it is being allocated to other cancers because they re seeing in some cases more progress being made.
3
SPEAKER_00
but pancreatic cancer really needs more money coming into the system so more research can be done which I think is a really critical aspect of this and that is that your voice matters and we need more people being active out there trying to get more money aimed at not only PanCan but helping research facilities and our major scientific universities to have the funding to do more research to go after
4
SPEAKER_02
this.
4
SPEAKER_00
That s exactly right.
4
SPEAKER_00
If the constituents are passionate about something, we need to transmit that to our elected officials, and they need to make sure that s heard in when they re making policy decisions and funding decisions.
4
SPEAKER_00
A really good example of that is that there s a Department of Defense allocation for funding for certain cancer types.
4
SPEAKER_00
And a couple years ago, our voices were loud enough and we were effective enough in making sure that there s an allocation for pancreatic cancer research through the Department of Defense, through the congressionally directed medical research programs.
4
SPEAKER_00
So that is just a clear way of which raising our voices can result in real dollars that go into really good research, really innovative research, the type of stuff that isn t necessarily done by other government agencies, and that can really contribute to getting us where we want to go with improving outcomes from pancreatic cancer.
4
SPEAKER_02
I have a friend here who unfortunately has had cancer six times.
4
SPEAKER_02
He hasn t had pancreatic cancer.
4
SPEAKER_02
Thank God.
4
SPEAKER_02
He has written a book and he has told me that regardless of what type of cancer you have, the most important thing is for you to realize that you are the CEO of your life.
4
SPEAKER_02
And that the way he words it is you need to run your cancer journey as if it s running a business, because there s so many elements of this from planning out your trips to the doctors who you need to seek out.
4
SPEAKER_02
how you need to canvas that, to where you need to put your money, to preparing for trips, to understanding your caregivers, everything.
4
SPEAKER_02
Is that an analogy that you would recommend as well?
4
SPEAKER_00
Yeah, well, certainly the voice of experience, but yes, we would very much
4
SPEAKER_00
advocate that you need to be your own advocate when you re faced with a disease like this, and that asking questions, probing on things, understanding, getting knowledge so that you can make good decisions, those are all a critical part to any
4
SPEAKER_00
big decisions and your cancer treatment is going to be a big decision.
4
SPEAKER_00
And so it really does.
4
SPEAKER_00
I would agree with your friend that taking some, some responsibility and some accountability for this, not just letting it happen, but being a very active participant in this is, is critical.
4
SPEAKER_00
It s, it s the way to really get the best results.
4
SPEAKER_02
And then Lynn, lastly, looking forward, what is your vision for the future of pancreatic cancer research and the possible potential for a cure?
4
SPEAKER_00
Yeah, I am optimistic that we will be able to identify pancreatic cancer early.
4
SPEAKER_00
that we will be able to bring all the tools at our disposal to its eradication, and that we ll be able to control it.
4
SPEAKER_00
I think it ll be a long time before we re able to prevent it, but I think we ll be able to control it and to live a normal, healthy life.
4
SPEAKER_00
And that s really the goal.
4
SPEAKER_00
And I am optimistic that there are some very passionate and dedicated people in this field
4
SPEAKER_00
that really want to make a difference and I think we will just continue to work at it until that happens.
4
SPEAKER_02
Thank you, Lynn.
4
SPEAKER_02
Any closing remarks you wanted to give or any more information you wanted to share about PanCan?
4
SPEAKER_00
Well, just if you find yourself in need of information about pancreatic cancer, pancan.org.
4
SPEAKER_00
We are here.
4
SPEAKER_00
This is what we do.
4
SPEAKER_00
We want to help you be your best advocate and give you the resources, the information that you need to make your best decisions.
4
SPEAKER_00
And we are optimistic and are creating hope for the future.
4
SPEAKER_02
a person, the audience understands once you called up hand can, if you are a person who s been recently diagnosed, my understanding is you re assigned to a case manager who kind of works with you, helps you figure out what are your best treatment options?
4
SPEAKER_02
Where would you go for something like the Whipple surgery?
4
SPEAKER_02
And then if it s in a more advanced stage, but you ve got resources also that could help you with your diet, help you with,
4
SPEAKER_02
planning, your whole treatment allocation, and then of course where the clinical trials are.
4
SPEAKER_00
Yeah, our case managers are wonderful.
4
SPEAKER_00
This is what they do.
4
SPEAKER_00
And they will listen and, and customize really give you the kind of information you need.
4
SPEAKER_00
Then if you need to call back a week, two weeks, a month, whatever later with another question, fine, you ll get the same person.
4
SPEAKER_00
You ll be able to really interact with that person and they can really help.
4
SPEAKER_00
And our goal is to get people on the right track.
4
SPEAKER_00
So have the right team for their care.
4
SPEAKER_00
and support, get the right treatment and get the right tests to get the right treatment.
4
SPEAKER_00
So if we do all those things, I think that really puts people on the right track for dealing with this disease.
4
SPEAKER_02
Well, Lynn, thank you so much for joining us today.
4
SPEAKER_02
It was our honor to bring you on and hopefully spread some information that the audience can use to help a loved one or potentially help themselves.
4
SPEAKER_02
Thank you for being here.
4
SPEAKER_00
Well, thank you very much for the opportunity to spread the word and I wish you and your sister all the best.
4
SPEAKER_02
Thank you so much.
4
SPEAKER_02
I was so honored to be able to do that interview, especially on pancreatic cancer awareness day with Dr. Lynn Matreson.
4
SPEAKER_02
And I wanted to thank Lynn and PanCan for the honor of having her appear on today s show links to all things.
4
SPEAKER_02
Lynn will be in the show notes at passionstruck.com.
4
SPEAKER_02
Please use the website links.
4
SPEAKER_02
If you purchase any of the books from the guests that we feature here on the show,
4
SPEAKER_02
Videos are on YouTube and both John R. Miles and Passionstruck clips.
4
SPEAKER_02
I have an exciting announcement that my brand new book, Passionstruck, is now available for pre-order at Amazon, Barnes & Noble, or wherever you purchase books.
4
SPEAKER_02
Links will also be in the show notes.
4
SPEAKER_02
You can go to LinkedIn and sign up for my newsletter, Work Intentionally.
4
SPEAKER_02
You can find me on all the social platforms at John R. Miles, or you can sign up for my personal development newsletter, Live Intentionally, at passionstruck.com.
4
SPEAKER_02
Advertiser deals and discount codes are in one convenient place.
4
SPEAKER_02
PassionStruck.com slash deals.
4
SPEAKER_02
You re about to hear a preview of the PassionStruck podcast interview I did with executive coach Jerry Colonna, who uses the skills that he s learned as a venture capitalist to help entrepreneurs and business leaders.
4
SPEAKER_02
He is a co-founder and CEO of Reboot, the executive coaching and leadership development company, host of the Reboot podcast and author of the great new book, Reunion, Leadership and the Longing to Belong.
4
SPEAKER_01
If you grow up socialized to, quote, not be vulnerable, then you are, in effect, distancing yourself from your own heart.
4
SPEAKER_01
And how can one come to know oneself if you don t even know your heart?
4
SPEAKER_01
I have a reputation, John.
4
SPEAKER_01
Wired Magazine did an article on me, and the headline was, This Man Makes Founders Cry.
4
SPEAKER_01
The joke is that I make people cry because I ask them how they are.
4
SPEAKER_01
But I ask it like I really care.
4
SPEAKER_01
And what typically causes the tears to fall at that point is the realization that they have not been heard and they may not even be able to answer the question, how am I themselves?
4
SPEAKER_01
Because they re so disconnected from themselves.
4
SPEAKER_02
The fee for this show is that you share it with family or friends when you find something useful or interesting.
4
SPEAKER_02
If you know someone who is dealing with pancreatic cancer in any shape or form, then please share this very important episode with them.
4
SPEAKER_02
The greatest compliment that you can give us is to share the show with those that you love and care about.
4
SPEAKER_02
In the meantime, do your best to apply what you hear on the show so you can live what you listen.
4
SPEAKER_02
Until next time, go out there and become a passion star.